100 related articles for article (PubMed ID: 2515201)
1. High-performance liquid chromatographic determination of mitomycin C in rat and human plasma and urine.
Dalton JT; Geuns ER; Au JL
J Chromatogr; 1989 Oct; 495():330-7. PubMed ID: 2515201
[No Abstract] [Full Text] [Related]
2. Determination of mitomycin C in plasma, serum and urine by high-performance liquid chromatography with ultra-violet and electrochemical detection.
Tjaden UR; Langenberg JP; Ensing K; van Bennekom WP; de Bruijn EA; van Oosterom AT
J Chromatogr; 1982 Nov; 232(2):355-67. PubMed ID: 6818240
[TBL] [Abstract][Full Text] [Related]
3. Liquid chromatographic determination of mitomycin C in human plasma and urine.
Eksborg S; Ehrsson H; Lindfors A
J Chromatogr; 1983 May; 274():263-70. PubMed ID: 6409914
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin C determination using loop-column extraction: a rapid and sensitive high-performance liquid chromatographic assay for pharmacokinetic studies with Spherex starch particles.
Czejka MJ; Jäger W; Schüller J
J Chromatogr; 1989 Dec; 497():336-41. PubMed ID: 2516522
[No Abstract] [Full Text] [Related]
5. Pharmacokinetics of mitomycin C in dogs: application of a high-performance liquid chromatographic assay.
Barbhaiya RH; Papp EA; Van Harken DR; Smyth RD
J Pharm Sci; 1984 Sep; 73(9):1220-3. PubMed ID: 6436466
[TBL] [Abstract][Full Text] [Related]
6. Determination of mitomycin C in serum by high-performance liquid chromatography with dual-electrode coulometric detection.
Ohkubo T; Nambara T
J Chromatogr; 1990 May; 527(2):441-6. PubMed ID: 2117616
[No Abstract] [Full Text] [Related]
7. Liquid chromatographic determination of mitomycin C in human plasma and urine.
Den Hartigh J; van Oort WJ; Hulshoff A
J Chromatogr; 1984 Mar; 306():444-5. PubMed ID: 6425351
[No Abstract] [Full Text] [Related]
8. Liquid chromatographic determination of mitomycin C in plasma and urine.
Eksborg S; Ehrsson H; Lindfors A
J Chromatogr; 1984 Mar; 306():446-7. PubMed ID: 6425352
[No Abstract] [Full Text] [Related]
9. Determination of the new anticancer agent KW 2149, 7-N-[2-[2-(gamma-L-glutamylamino)ethyl)dithio)ethyl]mitomycin C, an analogue of mitomycin C.
Pattyn G; van Oosterom AT; de Bruijn EA; Tjaden UR
J Chromatogr; 1991 Mar; 564(1):352-4. PubMed ID: 1860933
[TBL] [Abstract][Full Text] [Related]
10. Determination of mitomycin C in biomedical specimens by high-performance liquid chromatography.
Kono A; Hara Y; Eguchi S; Tanaka M; Matsushima Y
J Chromatogr; 1979 Nov; 164(3):404-6. PubMed ID: 544616
[No Abstract] [Full Text] [Related]
11. Simultaneous determination of a new anticancer agent (NB-506) and its active metabolite in human plasma and urine by high-performance liquid chromatography with ultraviolet detection.
Takenaga N; Ishii Y; Monden S; Sasaki Y; Hata S
J Chromatogr B Biomed Appl; 1995 Dec; 674(1):111-7. PubMed ID: 8749258
[TBL] [Abstract][Full Text] [Related]
12. Reversed-phase high-performance liquid chromatographic determination of mitomycin C in human serum.
Buice RG; Sidhu P; Gurley BJ; Niell HB
Ther Drug Monit; 1984; 6(1):113-5. PubMed ID: 6424274
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of mitomycin C in rabbit and human.
van Hazel GA; Kovach JS
Cancer Chemother Pharmacol; 1982; 8(2):189-92. PubMed ID: 6809356
[TBL] [Abstract][Full Text] [Related]
14. Isolation of albomitomycins from solutions of 7-amino substituted mitomycins; mitomycin C and KW-2149.
Kono M; Saitoh Y; Kasai M; Shirahata K
J Antibiot (Tokyo); 1995 Feb; 48(2):179-81. PubMed ID: 7706131
[No Abstract] [Full Text] [Related]
15. Determination of the anti-tumor agent, 10-chloro-5-(2-dimethylaminoethyl)-7h-indolo[2,3-c] quinoline-6(5h)-one. HCl in blood or plasma by high-performance liquid chromatography.
Strojny N; D'Arconte L; de Silva JA
J Chromatogr; 1981 Apr; 223(1):111-21. PubMed ID: 6265483
[TBL] [Abstract][Full Text] [Related]
16. Chemical modification of DNA with muta-carcinogens. III. Reductive alkylation of DNA with mitomycin C.
Hashimoto Y; Shudo K
Environ Health Perspect; 1985 Oct; 62():219-22. PubMed ID: 3936706
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combination.
van Hazel GA; Scott M; Rubin J; Moertel CG; Eagan RT; O'Connell MJ; Kovach JS
Cancer Treat Rep; 1983 Sep; 67(9):805-10. PubMed ID: 6411337
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells.
Siegel D; Gibson NW; Preusch PC; Ross D
Cancer Res; 1990 Dec; 50(23):7483-9. PubMed ID: 1701346
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic analysis of felotaxel, a novel anti-cancer drug, in rat plasma and in human plasma and urine.
Yan L; YanYan J; MinChun C; Jing Y; Ying S; ChengTao L; Jie G; CaiYang L; ZhenXing Z; AiDong W; Yi D
J Chromatogr Sci; 2013 Mar; 51(3):292-6. PubMed ID: 22933511
[TBL] [Abstract][Full Text] [Related]
20. The stability and antitumor activity of recycled (intravesical) mitomycin C.
Hopkins SC; Buice RG; Matheny R; Soloway MS
Cancer; 1984 May; 53(10):2063-8. PubMed ID: 6423261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
